Recursion Pharmaceuticals and Exscientia announce merger to transform drug development
Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths to form a formidable entity in drug ... Read More
Owkin and AWS join forces to transform precision medicine
Owkin, a pioneering TechBio company known for combining human and artificial intelligence to tailor treatments for individual patients, has announced a strategic collaboration with Amazon ... Read More
Owkin and AWS forge path to precision medicine with strategic collaboration
Owkin, a pioneering TechBio company, has announced a strategic collaboration with Amazon Web Services (AWS) to innovate in the field of drug discovery, enhance clinical ... Read More
SCIEX launches Echo MS+ System to enhance drug discovery through advanced mass spectrometry
SCIEX, a world-renowned leader in life science analytical technologies, introduced the Echo MS+ system at the Society for Laboratory Automation and Screening (SLAS) 2024 conference. ... Read More
Absci, PrecisionLife collaborate to develop novel biotherapeutics for chronic diseases
Absci (Nasdaq: ABSI), a generative AI drug creation company, and PrecisionLife, a leader in computational biology, today announced a significant collaboration. This partnership is set ... Read More
Perpetual Medicines secures $8m for peptide drug discovery platform
Perpetual Medicines, a frontrunner in computational peptide therapeutics, recently announced an impressive $8 million seed financing round, spearheaded by Chengwei Capital. This significant financial injection ... Read More
CAS, Molecule.one to collaborate on advanced synthesis design technologies
In a significant development in the realm of drug discovery, CAS, a subsidiary of the American Chemical Society, has teamed up with tech-bio front-runner Molecule.one. ... Read More
Hewlett Packard Enterprise to build TSUBAME4.0 supercomputer for Tokyo Tech
Hewlett Packard Enterprise (HPE) has been chosen to construct the TSUBAME4.0 by the Tokyo Institute of Technology (Tokyo Tech) Global Scientific Information and Computing Center ... Read More
BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery
German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration of around £362 million in cash and ... Read More
Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline
Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million, in a move to considerably expand its ... Read More